Maraviroc showed a similar effect as the knockdown of CCR5 on sensitizing the xenografts to cisplatin treatment, although maraviroc alone barely inhibited tumor growth (Figs. 7H and S6E). The gene discussed is CCR5; the disease is neoplasm.